logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Hypogonadotropic Hypogonadism

    FiltersReset Filters
    12 results

    • androgel

      (Testosterone)
      ASCEND Therapeutics U.S., LLC
      Usage: AndroGel 1.62% is indicated for testosterone replacement therapy in adult males with primary or hypogonadotropic hypogonadism due to various conditions. Its safety and efficacy in age-related hypogonadism and in males under 18 have not been established.

    • aveed

      (testosterone undecanoate)
      ENDO USA, Inc.
      Usage: AVEED is indicated for testosterone replacement therapy in adult males with conditions related to testosterone deficiency, including primary and hypogonadotropic hypogonadism. It should only be used when benefits outweigh risks, with safety and efficacy not established for age-related hypogonadism or in males under 18.

    • jatenzo

      (testosterone undecanoate)
      TOLMAR Inc.
      Usage: JATENZO (testosterone undecanoate) is indicated for testosterone replacement therapy in adult males with conditions leading to low testosterone, including primary and hypogonadotropic hypogonadism. It is not established for safety and efficacy in males under 18 years old.

    • natesto

      (testosterone)
      Acerus Pharmaceuticals Corporation
      Usage: Natesto is indicated for testosterone replacement therapy in adult males with primary or hypogonadotropic hypogonadism due to various causes, such as testicular failure or pituitary-hypothalamic injury. Its safety and efficacy in age-related hypogonadism and in males under 18 years have not been established.

    • pregnyl

      (CHORIOGONADOTROPIN ALFA)
      Organon LLC
      Usage: HCG is indicated for prepubertal cryptorchidism not caused by anatomical obstruction, selected cases of male hypogonadotropic hypogonadism, and for inducing ovulation and pregnancy in anovulatory women when secondary causes are addressed with human gonadotropins. It is not effective for obesity treatment.

    • testim

      (testosterone)
      Endo Pharmaceuticals Inc.
      Usage: TESTIM is indicated for testosterone replacement therapy in adult males with primary or hypogonadotropic hypogonadism due to conditions causing testosterone deficiency. It has not been established for age-related or late-onset hypogonadism, nor is it approved for use in males under 18 years.

    • testosterone

      (Testosterone)
      Actavis Pharma, Inc.
      Usage: Testosterone gel 1% is indicated for testosterone replacement therapy in adult males with primary or hypogonadotropic hypogonadism due to various causes. Its safety and efficacy have not been established in age-related hypogonadism or for males under 18 years old.

    • testosterone

      (Testosterone)
      Actavis Pharma, Inc.
      Usage: Testosterone topical solution is indicated for replacement therapy in males with primary or hypogonadotropic hypogonadism due to conditions such as testicular failure or pituitary-hypothalamic injury. Its safety and efficacy in age-related hypogonadism or in males under 18 have not been established.

    • testosterone

      (Testosterone)
      Lupin Pharmaceuticals, Inc.
      Usage: Testosterone gel 1.62% is indicated for replacement therapy in adult males with primary or hypogonadotropic hypogonadism associated with endogenous testosterone deficiency. It is not established for age-related hypogonadism or in males under 18 years. Different topical testosterone products may have varying dosages and instructions.

    • testosterone

      (Testosterone)
      Actavis Pharma, Inc.
      Usage: Testosterone gel 1% is indicated for replacement therapy in adult males with deficiencies in endogenous testosterone, specifically for primary and hypogonadotropic hypogonadism. Its safety and efficacy in age-related hypogonadism or males under 18 have not been established.